Rectus sheath hematoma.
Rectus sheath hematoma (RSH) is a known complication of anticoagulation therapy and a source of potential morbidity and mortality. Early diagnosis and appropriate treatment may help to prevent complications including hemodynamic instability, the abdominal compartment syndrome or multiorgan dysfunction. Although the diagnosis can be made clinically, it can be confirmed with computed tomography of the abdomen. Most patients can be managed conservatively; however, it is often necessary to suspend anticoagulation in the acute setting. Rectus sheath hematoma is not a contraindication to resuming anticoagulation once the hematoma has been adequately managed and the patient has returned to a stable clinical baseline.
Osinbowale
Olusegun
O
Section of Vascular Medicine, Department of Cardiology Ochsner Clinic Foundation, New Orleans, LA 70121, USA. oosinbowale@ochsner.org
Bartholomew
John R
JR
D015746:Abdominal Pain / Q000209:etiology; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage*; D000933:Antifibrinolytic Agents / Q000008:administration & dosage; D001777:Blood Coagulation / Q000187:drug effects; D017707:Erythrocyte Transfusion; D006406:Hematoma / Q000097:blood / Q000139:chemically induced* / Q000150:complications / Q000000981:diagnostic imaging / Q000628:therapy; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D017568:Rectus Abdominis / Q000000981:diagnostic imaging / Q000187:drug effects*; D014057:Tomography, X-Ray Computed; D014812:Vitamin K / Q000008:administration & dosage
D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D014812:Vitamin K